Polar Capital Holdings’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,636
Closed -$1.13M 274
2025
Q1
$1.13M Sell
3,636
-276,190
-99% -$81.6M 0.01% 270
2024
Q4
$72.9M Sell
279,826
-102,112
-27% -$30.3M 0.41% 64
2024
Q3
$123M Sell
381,938
-121,172
-24% -$39.6M 0.59% 39
2024
Q2
$157M Buy
503,110
+133,764
+36% +$39.3M 0.93% 24
2024
Q1
$105M Buy
369,346
+124,354
+51% +$36.4M 0.55% 46
2023
Q4
$70.6M Buy
244,992
+223,272
+1,028% +$60.8M 0.43% 66
2023
Q3
$5.84M Sell
21,720
-1,672
-7% -$417K 0.04% 217
2023
Q2
$5.19M Hold
23,392
0.03% 230
2023
Q1
$5.66M Sell
23,392
-2,069
-8% -$508K 0.04% 226
2022
Q4
$6.69M Hold
25,461
0.05% 219
2022
Q3
$5.74K Sell
25,461
-3,256
-11% -$789K 0.04% 236
2022
Q2
$6.99K Hold
28,717
0.04% 222
2022
Q1
$6.94K Hold
28,717
0.03% 245
2021
Q4
$6.46K Buy
28,717
+2,495
+10% +$527K 0.02% 250
2021
Q3
$5.58K Sell
26,222
-94,632
-78% -$21.8M 0.02% 271
2021
Q2
$29.5K Buy
120,854
+52,435
+77% +$12.9M 0.13% 134
2021
Q1
$17M Sell
68,419
-17,500
-20% -$4.18M 0.11% 175
2020
Q4
$19.8M Buy
+85,919
New +$19.8M 0.12% 162

Other funds holding AMGN

Polar Capital Holdings's AMGN Position: Q2 2025 in Review

Polar Capital Holdings sold out of Amgen (AMGN) in Q2 2025, closing a stake of 3,636 shares — an estimated $1.13M sold.

Polar Capital Holdings first reported a position in AMGN in Q4 2020 and held it in 18 quarters. The position peaked at $157M in Q2 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Polar Capital Holdings reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Polar Capital Holdings sold 3,636 Amgen shares in Q2 2025, an estimated $1.13M.
  • Polar Capital Holdings first reported a position in Amgen in Q4 2020 and held it in 18 quarters.
  • Polar Capital Holdings's Amgen position peaked at $157M in Q2 2024.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Polar Capital Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.